Headache Medicine Certification Examination Committee Contributors
Jerry W. Swanson, MD, Chair, Mayo Clinic – Rochester
Disclosures: Receives compensation from UpToDate for editorial services.
Robert G. Kaniecki, MD, Vice Chair, University of Pittsburgh Medical Center
Disclosures: Nothing to disclose.
P. Christopher H. Gottschalk, MD, Yale Neurology – Headache Division
Disclosures: Serves on Consulting and Advisory Boards for Linpharma, Impel, Currax, Biodelivery Sciences, Amneal Pharmaceuticals, Spherix Global Insights; Headache Cooperative of New England (HCNE), Board member; President, Alliance for Headache Disorders Advocacy.
Christopher B. Oakley, MD, Johns Hopkins University – Department of Child Neurology
Disclosures: Nothing to disclose.
Nina Riggins, MD, University of California San Diego
Disclosures: Consultant for Gerson Lehrman Group; NeurologyLive Advisory Board - was compensated for editor's work on October 2021 issue; Compensated for lectures, presentations on behalf of AHS and as invited speaker at the American Association of Pain Psychology; research support Miles for Migraine; Dr. Riggins is principal investigator and her institution University of California received compensation for work with company Electrocore and Eli Lilly; Participated in compensated work with AcademicCME (publication); Was not compensated but received devices for Research Clinical trials from Theraspecs, Dolor technologies; board member of Miles for Migraine (noncompensated).
Hossain Ansari, MD, Kaizen Brain Center
Disclosures: Received compensation for: 1. Consultant for developing clinical trial, Neoma Pharma, Basel Switzerland 2. Consultant for editing clinal trial protocol, Biohaven Pharma, USA; Advisory boards: Impel Pharmaceutical; Speaker’s Bureau: Abbvie Pharmaceutical, Amgen Pharmaceutical, Elli Lilly Co, Biohaven Pharmaceutical, Lundbeck pharma, Collegium Pharmaceutical; Expert Witness for: 1. Litili Group 2. Foland, Wickens, Roper, Hofer & Crawford, P.C 3. MedLegal Network; Compensation from the AAN for authoring questions for the “Neuro Self-Assessment Exam” (Neuro SAE).
Thomas Berk, MD, NYU Langone Health
Disclosures: Receives compensation from Neura Health.
Debra G. Davis, MD, LSU Health – Shreveport
Disclosures: Nothing to disclose.
Stephanie J. Nahas, MD, Thomas Jefferson University/Jefferson Headache Center
Disclosures: Received consulting fees from Alder/Lundbeck (ended October 2021), Allergan/AbbVie, Amgen/Novartis (ended April 2021), Axsome (ended January 2022), BioDelivery Sciences (ended February 2022), Biohaven (ended November 2021), Eli Lilly (ended April 2022), Fenix Group International (ended July 2021), Nesos Corp (formerly Vorso Corp, ended September 2020), Teva (ended October 2021); advisory board compensation from Allergan/AbbVie, Nesos Corp (formerly Vorso Corp, ended September 2020); speakers bureau Eli Lilly (ended September 2021); editorial compensation received from American Academy of Neurology, American Headache Society, Evolve Med Ed, Massachusetts Medical Society, MedLink Neurology, MJH Life Sciences, NACCME, Neurology Learning Network, Pennsylvania Neurologic Society, Springer, WebMD/Medscape, Wolters-Kluwer; American Headache Society, At-Large Board Member; expert witness for Jackson & Campbell; research support Teva (Ended March 2021, payment to institution for 2% salary support).